Ignite Creation Date:
2024-05-06 @ 8:07 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06264921
Status:
RECRUITING
Last Update Posted:
2024-07-15
First Post:
2024-02-09
Brief Title:
A Study With NKT3447 for Adults With AdvancedMetastatic Solid Tumors
Sponsor:
NiKang Therapeutics Inc
Organization:
NiKang Therapeutics Inc
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Progesterone-receptor-positive Breast Cancer |
| Solid Tumor |
| Solid Tumor Adult |
| Advanced Solid Tumor |
| Metastatic Tumor |
| Ovarian Cancer |
| Ovarian Neoplasms |
| Ovarian Carcinoma |
| Metastatic Ovarian Carcinoma |
| Endometrial Cancer |
| Endometrial Neoplasms |
| Endometrial Diseases |
| Metastatic Endometrial Cancer |
| Metastatic Endometrial Carcinoma |
| Advanced Endometrial Carcinoma |
| Advanced Ovarian Carcinoma |
| Gastric Cancer |
| Advanced Gastric Carcinoma |
| Metastatic Gastric Cancer |
| Metastatic Gastric Carcinoma |
| Small-cell Lung Cancer |
| Small Cell Lung Carcinoma |
| Triple Negative Breast Cancer |
| Triple Negative Breast Neoplasms |
| Platinum-resistant Ovarian Cancer |
| Platinum-refractory Ovarian Carcinoma |
| CCNE1 Amplification |
| Hormone Receptor Negative Breast Carcinoma |
| Human Epidermal Growth Factor 2 Negative Carcinoma of Breast |